Navigation Links
Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients
Date:7/30/2008

of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Novartis

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, infectious disease, dermatological, GI and respiratory areas. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG (NYSE: NVS), which provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2007, the Group's continuing operations (excluding divestments in 2007) achieved net sales of USD 38.1 billion and net income of USD 6.5 billion. Approximately USD 6.4 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 98,000 full-time associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

References

(1) "Income, Poverty, and Health Insurance Coverage in the United States: 2006." U.S. C
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
2. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
3. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
4. Novartis and Sony Pictures Television Internationals Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America
5. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
6. Novartis Vaccines to Host Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
7. Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
8. Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
9. Novartis Vaccines Launches National Gift-Giving Program to Help Protect Loved Ones by Reserving an Influenza Vaccination
10. Dr. Web Makes Many Americans Question Trusted Health Providers
11. BCBSNC Makes Electronic Prescribing Available Statewide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... 15 In today,s academic medical centers, ... ever. Now the University HealthSystem Consortium (UHC) has ... Analysis: Achieving Cost Efficiencies in Health Care, ... environments. These new materials, developed with the input ... a practical guide to planning, implementing, and managing ...
(Date:12/14/2009)... ATLANTA, Dec. 14 Americold Realty Trust ("Americold") ... on Form S-11 with the U.S. Securities and Exchange ... offering of its common shares. The number of shares ... offering have not yet been determined. The common shares ... be sold by Americold. ,, The joint book-running ...
(Date:12/14/2009)... Dental Care (also known as Culver City Dentist ... care in Southern California. We provide treatments in general ... and periodontal treatments. Beverly Hills Dentist and ... with experienced and trusted dentists who provide these treatments ... is one of these trusted dentists. He is best ...
(Date:12/14/2009)... Sedwitz Heads up 900-Member Physician Staff , ... La ... Jolla have elected Marc Sedwitz, MD, as the new chief of ... head of the 900-member physician team on Jan. 1, 2010. , ... as medical staff liaison to Scripps La Jolla’s administrative staff and ...
(Date:12/14/2009)... Calif., Dec. 14 Grubb & Ellis Healthcare REIT ... authorized a daily distribution to stockholders of record as of ... commencing on Jan. 1, 2010 and ending on Feb. 28, ... days in the calendar year and will be equal to ... price of $10.00 per share. These distributions will be ...
Breaking Medicine News(10 mins):Health News:University HealthSystem Consortium Offers Value Analysis Professionals Insightful New Resources 2Health News:Americold Realty Trust Files Registration Statement for Proposed Initial Public Offering 2Health News:United Dental Care, Gentle Care, Trusted Dentists 2Health News:United Dental Care, Gentle Care, Trusted Dentists 3Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 3Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 2Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 3
... 4 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX :,HAE), ... plasma-derived protein products for commercialization,announces that it ... fractionation,facility for the production of its proprietary ... clinical trials, leading to commercial launch., ...
... BasicPlus Health,Insurance of Roswell, Ga., announced today that ... Healthcare Inc. of Columbia, S.C., to,include a network ... benefit health insurance plans., The agreement means ... (for individuals) limited benefit plans have the,option of ...
... New e-book outlines major issues and best practices for handling fresh, produce ... ... to know., ATLANTA, June 4 Fresh ... have raised public awareness and,industry concern. At its biennial meeting in San ...
... Bethesda, MD The American Society for Investigative ... M. Engman, MD, PhD, Professor of Pathology and ... of the ASIP - Amgen Outstanding Investigative Award, ... experimental pathology funded by Amgen. Dr. Engman ...
... Licensed pesticide applicators who used chlorinated pesticides on more ... risk of diabetes, according to researchers from the National ... and incident diabetes ranged from a 20 percent to ... with the NIH,s National Institute of Environmental Health Sciences ...
... Unilens Vision Inc. (OTC,Bulletin Board: UVICF; ... distributes and markets specialty contact lenses,today revealed ... GP (Gas Permeable),products., Unilens, known as ... continues its tradition of providing outstanding programs,designed ...
Other Medicine News:Health News:Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility 2Health News:Insurance Company Includes Global Network Option in Limited Benefit Plans 2Health News:Insurance Company Includes Global Network Option in Limited Benefit Plans 3Health News:Chemstar Corporation Publishes New Insights on Fresh Produce Safety From CFP Workshop 2Health News:Long-term pesticide exposure may increase risk of diabetes 2Health News:Long-term pesticide exposure may increase risk of diabetes 3Health News:Unilens Vision Announces New Policies Aimed at Increasing Eye Care Professionals Profitability 2
(Date:12/14/2009)... Dec. 14 When staff from a ... apply the difficult to adjust and uncomfortable cubital ... Professional Products, Inc. (PPI) to develop a superior ... orthopaedic solutions for nearly five decades, responded with ... ), which it announced today. Simple to ...
(Date:12/14/2009)... Dec. 14 ... a leading provider of tools and services for ... that it has completed the sale of Xenogen ... pre-clinical CRO services, to Taconic Farms, Inc. for ... Caliper as part of Caliper,s acquisition of Xenogen ...
(Date:12/14/2009)... Dec. 14 Travelers of Interstate 70 west ... become a bit more colorful when 10 multicolored art ... is named going home , will eventually include ... a graduate student at Herron School of Art and ... Public Life. ,, Eli Lilly and Company (NYSE: ...
Breaking Medicine Technology:New Cubital Tunnel Splint Specially Designed for Comfort and Less Cumbersome Fit 2Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 2Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 3Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 4Public Art to Complete Transformation of Key Gateway into Indianapolis 2Public Art to Complete Transformation of Key Gateway into Indianapolis 3Public Art to Complete Transformation of Key Gateway into Indianapolis 4BIA Publishes White Paper 3A ISO 9000 Role in Document Review Emphasizes Quality Equals Defensibility 5183 1BIA Publishes White Paper 3A ISO 9000 Role in Document Review Emphasizes Quality Equals Defensibility 5183 2BIA Publishes White Paper 3A ISO 9000 Role in Document Review Emphasizes Quality Equals Defensibility 5183 3Glove Nation Launches Major Website Upgrade 14329 1Glove Nation Launches Major Website Upgrade 14329 2High Cost of Chronic Illness Spotlights Need for Case Management Professionals 58738 1High Cost of Chronic Illness Spotlights Need for Case Management Professionals 58738 2
... Proof-of-Principle Studies -, GAITHERSBURG, Md., April 3, ... announced that it has signed an agreement,with Merck ... the use of the Iomai needle-free immunostimulant patch., ... exclusive license. These,preclinical proof-of-principle studies will be conducted ...
... announced a,cash injection from Midroc New Technology AB who ... will be used for,the further development of DermaGen,s first ... clinical phase 2a study in patients with Atopic,Dermatitis (AD), ... further develop the company,s R & D pipeline., ...
Other Medicine Technology:Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch 2Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch 3DermaGen AB Receives Over 1 Million Euros From a New Share Issue 2DermaGen AB Receives Over 1 Million Euros From a New Share Issue 3
The TEW Cranial/Spinal Retractor is designed for posterior fossa or intraspinal microsurgery where retraction is required....
... Infuse Bone Graft represents an rhBMP-2 ... combined with a bovine-derived absorbable collagen sponge ... tapered fusion device is indicated for spinal ... degenerative disc disease (DDD) at one level ...
... dowels are threaded to dramatically ... and improve graft stability. Dense, ... blood cell saturation for osteogenesis. ... into the porous structure of ...
Lorenz 2.0 mm titanium system for the midface provides an excellent alternative to lower profile systems in areas of the midface where greater fixation is needed....
Medicine Products: